4th Quarter - Report

GOVERNMENT COUNSEL, LLC for PRIME THERAPEUTICS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H.R. 133-Consolidated Appropriations Act of 2021 relating to PBM transparency and disclosure.

LobbyistCovered position, as disclosed
HENRY W MENN Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 133 (116th)

Medicare/Medicaid MMM

Issues relating to pharmacy direct and indirect remuneration in Medicare Part D.

LobbyistCovered position, as disclosed
HENRY W MENN Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

S. 1895-Lower Health Care Costs Actrelating to 306;Removal of Safe Harbor Protection for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection Final Rule (RIN: 0936-AA080).

LobbyistCovered position, as disclosed
HENRY W MENN Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1895 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.